BHVN

Biohaven (BHVN)

About Biohaven (BHVN)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Details

Daily high

$9.82

Daily low

$9.29

Price at open

$9.70

52 Week High

$45.87

52 Week Low

$7.48

Market cap

1.0B

Dividend yield

0.00%

Volume

31,475

Avg. volume

4.5M

P/E ratio

-1.26

Biohaven News